Auna Discloses That A Colombia Contract Resulted In Additional Temporary Cost Pressure Due To An Unexpected High Incidence Of Advanced-Stage Cancer Cases; Reaffirms FY26 Adjusted EBITDA Growth At Low End Of 10%-14% Range
Auna S.A. ("Auna" or the "Company") (NYSE:AUNA), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today a preliminary update to its full-year 2026
Share
Why It Matters
Auna faced surprise costs in Colombia from many sick patients. But the company still expects steady profit growth this year.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.